BetterLife Pharma Inc. Operating Income Loss

• BetterLife Pharma Inc. showed a decrease of -405.1% in Operating Income Loss from 2018 to 2019.
• This data is from BetterLife Pharma Inc.'s annual report (Form 10-K), filed with the SEC on May 3, 2019.
• XBRL data for this metric is available from 2015 to 2019 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: -$1.16 million | Q4 2015: -$7.8 thousand | Q2 2016: -$3.33 million | Q3 2016: -$1.18 million | Q4 2016: -$690.3 thousand | Q2 2017: -$285.5 thousand | Q3 2017: -$248.8 thousand | Q4 2017: -$184.7 thousand | Q2 2018: -$1.88 million | Q3 2018: -$1.18 million | Q4 2018: -$1.41 million | Q2 2019: -$1.66 million.
• Over the full 5 years of available data (2015 to 2019), BetterLife Pharma Inc.'s Operating Income Loss has declined by 5,725.6%.
• Historical annual values: Fiscal year 2019: -$6.84 million | Fiscal year 2018: -$1.35 million | Fiscal year 2017: -$6.02 million | Fiscal year 2016: -$10.32 million | Fiscal year 2015: -$117.5 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026